| Online-Ressource |
Verfasst von: | Müller, Margarida Melo Mendes Jorge [VerfasserIn]  |
| Ouermi, Lucienne [VerfasserIn]  |
| Meissner, Peter [VerfasserIn]  |
| Compaoré, Guillaume [VerfasserIn]  |
| Coulibaly, Boubacar [VerfasserIn]  |
| Nebie, Eric [VerfasserIn]  |
| Krisam, Johannes [VerfasserIn]  |
| Klose, Christina [VerfasserIn]  |
| Kieser, Meinhard [VerfasserIn]  |
| Jahn, Albrecht [VerfasserIn]  |
| Lu, Guangyu [VerfasserIn]  |
| D'Alessandro, Umberto [VerfasserIn]  |
| Sié, Ali [VerfasserIn]  |
| Mockenhaupt, Frank Peter [VerfasserIn]  |
| Müller, Olaf [VerfasserIn]  |
Titel: | Safety and efficacy of artesunate-amodiaquine combined with either methylene blue or primaquine in children with falciparum malaria in Burkina Faso |
Titelzusatz: | a randomized controlled trial |
Verf.angabe: | Margarida Mendes Jorge, Lucienne Ouermi, Peter Meissner, Guillaume Compaoré, Boubacar Coulibaly, Eric Nebie, Johannes Krisam, Christina Klose, Meinhard Kieser, Albrecht Jahn, Guangyu Lu, Umberto D`Alessandro, Ali Sié, Frank Peter Mockenhaupt, Olaf Müller |
E-Jahr: | 2019 |
Jahr: | October 10, 2019 |
Umfang: | 16 S. |
Fussnoten: | Gesehen am 09.12.2019 |
Titel Quelle: | Enthalten in: PLOS ONE |
Ort Quelle: | San Francisco, California, US : PLOS, 2006 |
Jahr Quelle: | 2019 |
Band/Heft Quelle: | 14(2019,10) Artikel-Nummer e0222993, 16 Seiten |
ISSN Quelle: | 1932-6203 |
Abstract: | Artemisinin resistance is threatening global efforts for malaria control and elimination. Primaquine (PQ) and methylene blue (MB) are gametocytocidal drugs that can be combined with artemisinin-based combination therapy (ACT) to reduce malaria transmission, including resistant strains. Children (6-59 months) with uncomplicated falciparum malaria in Burkina Faso were treated with artesunate-amodiaquine (AS-AQ) and randomized to MB (15 mg/kg/day for 3 days) or PQ (0.25 mg/kg at day 2) with the aim to show non-inferiority of the MB regimen with regard to haematological recovery at day 7 (primary endpoint). MB-AS-AQ could not be shown to be non-inferior to PQ-AS-AQ (mean Hb difference between treatment groups on day 7 was -0.352, 95% CI -0.832-0.128, p = 0.0767), however, haemoglobin recovery following treatment was alike in the two study arms (day 7: mean 0.2±1.4 g/dl vs. 0.5±0.9 g/dl, p = 0.446). Occurrence of adverse events was similar in both groups, except for vomiting, which was more frequent in the MB than in the PQ arm (20/50 vs 7/50, p = 0.003). Adequate clinical and parasitological response was above 95% in both groups, but significantly more asexual parasites were cleared in the MB arm compared to the PQ arm already on day 1 (48/50, 96%, vs 40/50, 80%, p = 0.014). Moreover, P. falciparum gametocyte prevalence and density were lower in the MB arm than in the PQ arm, which reached statistical significance on day 2 (prevalence: 2/50, 4%, vs 15/49, 31%, p<0.001; density: 9.6 vs 41.1/μl, p = 0.024). However, it should be considered that PQ was given only on day 2. MB-ACT appears to be an interesting alternative to PQ-ACT for the treatment of falciparum malaria. While there is a need to further improve MB formulations, MB-ACT may already be considered useful to reduce falciparum malaria transmission intensity, to increase treatment efficacy, and to reduce the risk for resistance development and spread. Trial registration: ClinicalTrials.gov NCT02851108. |
DOI: | doi:10.1371/journal.pone.0222993 |
URL: | kostenfrei: Volltext: https://doi.org/10.1371/journal.pone.0222993 |
| kostenfrei: Volltext: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0222993 |
| DOI: https://doi.org/10.1371/journal.pone.0222993 |
Datenträger: | Online-Ressource |
Sprache: | eng |
Sach-SW: | Antimalarials |
| Artemisinin |
| Gametocytes |
| Malaria |
| Malarial parasites |
| Methylene blue |
| Plasmodium |
| Vomiting |
K10plus-PPN: | 1684882699 |
Verknüpfungen: | → Zeitschrift |
|
|
| |
Lokale URL UB: | Zum Volltext |
Safety and efficacy of artesunate-amodiaquine combined with either methylene blue or primaquine in children with falciparum malaria in Burkina Faso / Müller, Margarida Melo Mendes Jorge [VerfasserIn]; October 10, 2019 (Online-Ressource)